{
  "actions": [
    {
      "acted_at": "2021-04-14",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-04-14",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s1123-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "G000386",
      "district": null,
      "name": "Grassley, Chuck",
      "original_cosponsor": false,
      "sponsored_at": "2021-04-22",
      "state": "IA",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-04-14",
  "number": "1123",
  "official_title": "A bill to preserve non-interference under the Medicare part D Prescription Drug Benefit program.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "PING Act",
  "sponsor": {
    "bioguide_id": "B001243",
    "district": null,
    "name": "Blackburn, Marsha",
    "state": "TN",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-04-14",
  "subjects": [
    "Competition and antitrust",
    "Health",
    "Health care costs and insurance",
    "Inflation and prices",
    "Medicare",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-04-14",
    "date": "2021-09-14T13:18:03Z",
    "text": "Preserving Innovation for the Next Generation Act or the PING Act\n\nThis bill expresses the sense of the Senate that the current restrictions prohibiting the Centers for Medicare & Medicaid Services from negotiating the prices or establishing a formulary for drugs under the Medicare prescription drug benefit should not be repealed. The bill also prohibits the Center for Medicare and Medicaid Innovation from testing any model that would repeal or require a waiver of such restrictions."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "PING Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to preserve non-interference under the Medicare part D Prescription Drug Benefit program.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "PING Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Preserving Innovation for the Next Generation Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:49:21Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s1123.xml"
}